Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jafar Al-Sadir is active.

Publication


Featured researches published by Jafar Al-Sadir.


American Journal of Cardiology | 1978

Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy: II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel disease

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; William J. Rogers; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Robert A. Rosati; H.N. Oldham; Galen S. Wagner; Robert H. Peter; C.R. Conti; R.C. Curry; George R. Daicoff; Lewis C. Becker; G. Plotnick; Vincent L. Gott; Robert K. Brawley; James S. Donahoo; Richard S. Ross; Adolph M. Hutter; Roman W. DeSanctis

Abstract A prospective randomized study comparing intensive medical therapy with urgent coronary bypass surgery for the acute management of patients with unstable angina pectoris was carried out by nine cooperating medical centers under the auspices of the National Heart, Lung, and Blood Institute. Between 1972 and 1976, a total of 288 patients were entered into the study. All patients had transient S-T or T wave changes, or both, in the electrocardiogram during pain; 90 percent had pain at rest in the hospital, and 76 percent had multivessel coronary disease. The medically and surgically treated patients were comparable with respect to clinical, electrocardiographic and angiographic characteristics and left ventricular function. During the total study period, the hospital mortality rate was 5 percent in the surgical group and 3 percent in the medical group (difference not significant). The rate of in-hospital myocardial infarction was 17 and 8 percent in the respective groups (P In the 1st year after hospital discharge class III or IV angina (New York Heart Association criteria) was more common in medically than in surgically treated patients with one vessel disease (22 percent versus 3 percent, P The results indicate that patients with unstable angina pectoris can be managed acutely with intensive medical therapy, including the administration of propranolol and long-acting nitrates in pharmacologic doses, with adequate control of pain in most patients and no increase in early mortality or myocardial infarction rates. Later, elective surgery can be performed with a low risk and good clinical results if the patients angina fails to respond to intensive medical therapy.


American Journal of Cardiology | 1976

Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; William J. Rogers; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Robert A. Rosati; H.N. Oldham; Galen S. Wagner; Robert H. Peter; C.R. Conti; R.C. Curry; George R. Daicoff; Lewis C. Becker; G. Plotnick; Vincent L. Gott; Robert K. Brawley; James S. Donahoo; Richard S. Ross; Adolph M. Hutter; Roman W. DeSanctis

A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the eithical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.Abstract A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the ethical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.


Investigative Radiology | 1983

Methods for evaluating cardiac wall motion in three dimensions using bifurcation points of the coronary arterial tree.

Michael J. Potel; Jonathan M. Rubin; Steven A. Mackay; Alex Aisen; Jafar Al-Sadir; Richard E. Sayre

An accurate three-dimensional (3D) representation of heart wall motion would be an important means of evaluating cardiac function. To accomplish this, we have developed an interactive computer graphics system designed to enter the time-dependent 3D positions of bifurcations of the coronary arterial tree. These bifurcations are precise markers of the epicardial surface, and their motions accurately represent the motion of the underlying heart wall. We demonstrate techniques for calculating local wall motion, including displacement and velocity, for determining a time-dependent center-of-contraction point towards which the epicardium tends to move and for tracking the mechanical contraction wave using cross-correlation methods. We have applied these techniques to study seven patients with normal left ventriculograms and coronary arteriograms. We have found these methods to be generally applicable and to provide information not obtainable without 3D analysis.


American Journal of Cardiology | 1976

Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy. I. Report of protocol and patient population

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Paul A. Ebert; Robert A. Rosati; N. Oldham; B. Mittler; Robert H. Peter; C. R. Conti; Richard S. Ross; Robert K. Brawley; G. Plotnick; Vincent L. Gott; James S. Donahoo; Lewis C. Becker; Adolph M. Hutter; Roman W. DeSanctis; Herman K. Gold; Robert C. Leinbach

A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the eithical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.Abstract A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the ethical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.


The Annals of Thoracic Surgery | 1979

Calcific Stenosis of the Porcine Heterograft

John J. Lamberti; Bruce H. Wainer; Kenneth A. Fisher; Harischandra B. Karunaratne; Jafar Al-Sadir

We have encountered two cases of late calcification of the porcine heterograft. A patient in chronic renal failure died of sepsis and endocarditis fifteen months after replacement of the mitral and tricuspid valves. At postmortem examination, both heterograft valves exhibited severe calcification and thrombosis. A second patient with rheumatic heart disease and sickle cell disease underwent mitral valve replacement for severe regurgitation. Thirty months later, cardiac catheterization revealed prosthetic valve stenosis. The valve was replaced successfully, and the excised heterograft exhibited severe calcification with restriction of leaflet motion. Although calcification of the porcine heterograft is known to occur in patients with infection or disorders of calcium metabolism, dysfunction of the heterograft is rare in our experience.


American Journal of Cardiology | 1980

Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy: III. Results in patients with S-T segment elevation during pain

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; William J. Rogers; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Robert A. Rosati; H.N. Oldham; Galen S. Wagner; Robert H. Peter; C.R. Conti; R.C. Curry; George R. Daicoff; Lewis C. Becker; G. Plotnick; Vincent L. Gott; Robert K. Brawley; James S. Donahoo; Richard S. Ross; Adolph M. Hutter; Roman W. DeSanctis

Abstract A prospective randomized study comparing intensive medical therapy with urgent coronary bypass surgery for the acute management of patients with unstable angina pectoris was carried out by nine cooperating medical centers under the auspices of the National Heart, Lung, and Blood Institute. Between 1972 and 1976, a total of 288 patients were entered into the study; 79 of these (27 percent of the total study group) with 70 percent or more fixed obstruction in one or more coronary arteries had episodes of pain at rest associated with transient S-T segment elevation. Forty-two were randomized to medical and 37 to surgical therapy. The hospital mortality rate was 4.8 percent for the medical and 5.4 percent for the surgical group (difference not significant). The rate Of in-hospital myocardial infarction was 12 percent in the medical and 14 percent in the surgical group (difference not significant). During the 1st and 2nd years of follow-up, 25 percent in the medical and 15 percent in the surgical group complained of New York Heart Association class III or IV angina (difference not significant). During an average follow-up period of 42 months 45 percent of the medically treated patients later underwent surgery to relieve unacceptable angina. In the medical group 65 percent were working full- or part-time at the end of 1 year and 61 percent at the end of 2 years of follow-up; comparable figures for the surgically treated group were 63 and 68 percent. The results indicate that patients with unstable angina pectoris with transient S-T segment elevation during pain at rest with fixed obstruction of 70 percent or more in one or more coronary arteries do not differ significantly from patients with pain at rest associated with transient S-T segment depression or T wave inversion. The condition of such patients can be stabilized, and they can be managed with a maximal medical program including propranolol and long-acting nitrates in pharmacologic doses with good control of pain in most and no increase in rate of early mortality or myocardial infarction. Later, elective surgery can be performed with a lower risk and good clinical results if the patients angina fails to respond to intensive medical therapy.


Radiology | 1973

Clinical myocardial imaging with nitrogen-13 ammonia

Paul V. Harper; Jeffrey S. Schwartz; Robert N. Beck; Katherine A. Lathrop; Nicholas Lembares; Helen Krizek; Ignacio Gloria; Robert Dinwoodie; Andrew McLaughlin; Violet J. Stark; Carlos Bekerman; Paul B. Hoffer; Alexander Gottschalk; Leon Resnekov; Jafar Al-Sadir; Alvaro Mayorga; Harold L. Brooks

Myocardial infarcts may be clearly imaged using intravenous nitrogen-13 as carrier-free ammonia in doses of 10–30 mCi. This positron emitter is well imaged with the Nuclear Chicago HP Anger Camera with heavy collimation. The rapid blood disappearance of the agent gives good image contrast, and the short half-life and high isotope dosage give high-count density images with little radiation absorbed dose (5 mrad∕mCi total body).


American Journal of Cardiology | 1975

Biventricular dynamics during quantitated anteroseptal infarction in the porcine heart.

Harold L. Brooks; Jafar Al-Sadir; Jeffrey L. Schwartz; Barry H. Rich; Paul V. Harper; Leon Resnekov

The porcine heart has been shown to have close anatomic similarity to the human heart and was used as the experimental model in this study to gain further understanding of the early responses of both ventricles during acute anteroseptal myocardial infarction. High fidelity pressure and flow data were measured and multiple preejection and ejection variables were calculated for both ventricles. Infarct weight and distribution in both ventricles were quantitated. The standard infarction resulted from single stage ligation of the left anterior descending coronary artery just beyond its midpoint and second left ventricular branch. It comprised an average of 15.8 percent of total ventricular myocardium with an infarct/perfused ratio of 0.62 and a periinfarction transition zone of 7.5 mm, and involved significant portions of both ventricles and the interventricular septum. Performance characteristics of both ventricles were altered significantly by anteroseptal infarction and involved all phases of contraction--end-diastole, isovolumic systole and ventricular ejection. Although contractile alterations in the right ventricle were significant, they were somewhat delayed, yielding relatively low correlation coefficients with analogous left ventricular contractile indexes. These correlations became quite distinct during specific ventricular stresses. Comparison of anterolateral and anteroseptal infarction, matched in terms of infarct size, indicated that the right ventricular changes in the latter were related to direct involvement of the right ventricular free wall and septum rather than secondary to left ventricular alterations.


American Journal of Cardiology | 1987

Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility

Roberto M. Lang; Kenneth M. Borow; Alex Neumann; Jafar Al-Sadir; Steven B. Feinstein

Despite the recent interest in contrast-enhanced echocardiography as a means of defining myocardial perfusion, the effects of echo contrast agents on left ventricular (LV) contractility in humans remains poorly defined. This is particularly relevant because intracoronary injection of contrast agents used for angiographic visualization of coronary arteries produces significant alterations in LV hemodynamics. The relation of LV end-systolic wall stress (sigma es) to rate-corrected velocity of fiber shortening (Vcfc), a load-independent index of contractility, was studied in 7 patients undergoing elective coronary arteriography. Two-dimensional and targeted M-mode echocardiographic and central aortic pressure tracings were recorded during injections of standard volumes of angiographic (7 to 9 ml of nonsonicated Renografin-76) and echocardiographic (1.5 to 2.0 ml of sonicated Renografin-76) contrast agents into the left main coronary artery. The order in which agents were injected was randomly determined. Myocardial contractility was assessed under control conditions and 5 and 15 seconds after injection. Alterations in contractility relative to control were measured as the change in Vcfc after elimination of afterload (sigma es) as a confounding variable. An injection of Renografin-76 adequate for angiographic imaging of coronary artery anatomy resulted in a significant depression of LV contractility (p less than 0.001) in conjunction with a tendency toward increased afterload (p = 0.12); recovery occurred by 15 seconds after injection. The smaller amounts of sonicated Renografin-76 required to give adequate contrast enhancement of the myocardium did not alter LV contractile state or afterload.(ABSTRACT TRUNCATED AT 250 WORDS)


Circulation Research | 1975

Expansion of extracellular space in the nonischemic zone of the infarcted heart and concomitant changes in tissue electrolyte contents in the rat.

Philip I. Polimeni; Jafar Al-Sadir

The alterations in electrolyte content that occur in an infarcted zone of the heart have also been reported to occur in a similar manner, although to a far less degree, in the distant, apparently normal zones of the heart. These alterations in the nonischemic myocardium have usually been tabulated without comment, presumably because their magnitudes approach values of statistical dispersion. Our measurements of electrolyte content in the normal zone of the infarcted rat heart confirmed that all of the electrolyte contents were slightly modified. There was a rise in sodium, calcium, and chloride and a decline in potassium and magnesium. In addition, the extracellular space ([MC]sucrose) in this zone was elevated by nearly 15%. We have postulated a mechanism for this elevation based on an increase in the net filtration rate through myocardial capillaries. The expansion of the extracellular space can account for all of the electrolyte changes in the normal zone with the exception of the alteration in calcium. Therefore, there is no basis for assuming that these myocardial alterations reflect general movements of electrolytes down their electrochemical gradients. We suggest that the increment in the nominal concentration of cellular calcium is related to a compensatory mechanism that allows the reduced mass of functional myocardium to contract more vigorously.

Collaboration


Dive into the Jafar Al-Sadir's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harold L. Brooks

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles E. Rackley

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John A. Mantle

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicholas T. Kouchoukos

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Richard O. Russell

University of Alabama at Birmingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge